Why Janux Therapeutics Stock Soared as the Market Sagged Today
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Clinical-stage biotech Janux Therapeutics (NASDAQ: JANX) was a standout title on a gloomy Wednesday stock market. As investors fretted about an unfavorable inflation report from the federal government, bulls piled into the company’s shares on a report that it might be for sale. A
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1451277892-5d6677cb7ffe42999ba03f993d1a1ba8.jpg "Are My Social Security Disability Benefits Taxable?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1358880761-82e600bfa20f4c2a8c48dc39cebeb0b0.jpg "<div>Accountant vs. Controller: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/Primary-Image-td-bank-cd-rates-march-2023-7482856-1d7d5a82f0ca496b9b1d63739cd7f567.jpg "TD Bank CD Rates: November 2024")